EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 24.10
-0.10 (-0.41%)
Mar 26, 2026, 4:35 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 103.89 million as of March 26, 2026. Its market cap has increased by 16.83% in one year.
Market Cap
103.89M
Enterprise Value
92.82M
Revenue
51.56M
Ranking
n/a
PE Ratio
51.29
Stock Price
24.10
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 103.89M, an increase of 4,469.77%. That is a compound annual growth rate of 18.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 104.33M | -8.94% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 79.07B |
| Haleon | 32.06B |
| Smith & Nephew | 10.24B |
| Diaceutics | 121.43M |
| Scancell Holdings | 116.75M |
| Shield Therapeutics | 86.01M |
| INSPECS Group | 84.39M |